Treatment of vulvovaginal candidiasis during pregnancy
The article presents the results run the drug medicine in the treatment of candidal vaginitis in pregnant women. The obtained data allow to evaluate the integrated effect clinically researched the drug as highly effective. The effect of treatment after treatment (7 days) vehicle name was observed in 95.7% of patients, a positive clinical effect was still present in 83.0% of postpartum women. No side effects, the ease and convenience of use, the clinical efficacy of the drug allow us to recommend Vagiclin for the treatment of vulvovaginal candidiasis in pregnant women. Combination Vagicline of clindamycin and clotrimazole allows more effective in influencing a wide range of causative agents of vaginitis during pregnancy